CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,927
-26.2%
12,4300.0%0.00%
Q2 2023$17,526
-11.3%
12,4300.0%0.00%
Q1 2023$19,764
+8.9%
12,4300.0%0.00%
Q4 2022$18,148
-66.4%
12,4300.0%0.00%
Q3 2022$54,000
-85.7%
12,430
-84.3%
0.00%
Q1 2022$377,000
+19.7%
79,118
-8.1%
0.00%
Q4 2021$315,000
-54.4%
86,0600.0%0.00%
Q3 2021$691,000
-27.3%
86,060
+2.7%
0.00%
Q2 2021$951,00083,7920.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,120,0000.80%
Samsara BioCapital, LLC 689,709$2,676,0000.71%
BVF INC/IL 3,614,662$14,025,0000.68%
HAMILTON LANE ADVISORS LLC 71,491$277,0000.11%
MAI Capital Management 647,950$2,514,0000.05%
Laurion Capital Management LP 698,000$2,708,0000.04%
Jasper Ridge Partners, L.P. 92,939$361,0000.02%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$80,0000.02%
Ergoteles LLC 155,562$604,0000.02%
Clear Harbor Asset Management, LLC 25,000$97,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders